fumarates has been researched along with Hypophosphatemia* in 2 studies
2 other study(ies) available for fumarates and Hypophosphatemia
| Article | Year |
|---|---|
Hypophosphatemia in people with HIV: no benefit when switching from tenofovir disoproxil fumarate to tenfovir alafenamide.
Treatment with tenofovir disoproxil fumarate (TDF) has been associated with hypophosphatemia mainly because of injury of the renal proximal tubulus. Studies on the impact of tenfovir alafenamide (TAF) on phosphate homeostasis in people with HIV (PWH) are limited. Prompted by a patient with phosphate wasting under tenofovir but no other evidence for tubular dysfunction, a retrospective cohort analysis with 102 PWH revealed that hypophosphatemia remained largely unchanged after switching from TDF to TAF. Topics: Anti-HIV Agents; Fumarates; HIV Infections; Humans; Hypophosphatemia; Retrospective Studies; Tenofovir | 2021 |
Longterm treatment of psoriasis using fumaric acid preparations can be associated with severe proximal tubular damage.
Fumaric acid preparations are used as longterm and effective treatment of psoriasis. Apart from gastrointestinal, dermatological and hematological side-effects, transient renal damage was observed during treatment with fumaric acid. The case of a 38 year old woman who was treated with fumaric acid (420 mg bid) for 5 years before she complained of fatigue and weakness. According to clinical laboratory she had developed severe proximal tubular damage. Hypophosphatemia, glycosuria and proteinuria persisted although medication was stopped immediately. Topics: Adult; Fanconi Syndrome; Female; Fumarates; Glycosuria; Humans; Hypophosphatemia; Proteinuria; Psoriasis; Time | 1999 |